Question 7191 — human blood and organs

Summary

Mr. Quentin Bataillon alerts the Minister of Health and Prevention about the situation at the French Blood Establishment. The EFS, created in 2000 and despite several reforms, must today face several difficulties which are accumulating and leading to questions about its future. Indeed, donations are decreasing, staff are fewer and fewer and finances are sorely lacking. The board of directors also had to vote for a deficit budget of 20 million euros. Operational capacities do not allow the deployment of a sufficient collection offer. This then implies a shortage for patients but also for the manufacture of medicines derived from blood. It is also a national economic issue to the extent that these drugs are manufactured in France, guaranteeing the security of independence. However, if the Arras factory announces a need for three million liters by 2025 to produce at full capacity. The situation of the EFS has deteriorated due to the epidemic crisis, it is at an important turning point in its history and its model. To preserve it, it is imperative to give the EFS the financial, material and human resources to ensure its public service mission: collecting blood from volunteers. The difficulties that the EFS encounters are not isolated, they are all French health system which is now called into question. It is a vital link that must be saved. He therefore wishes to know his intentions to guarantee the sustainability of the EFS and beyond, to guarantee the French model of voluntary blood donation.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.